Liang Zhao
Director/Board Member bij MICROPORT CARDIOFLOW MEDTECH CORPORATION
Vermogen: 41 629 $ op 31-03-2024
Profiel
Liang Zhao is currently the Director at Shanghai MicroPort CardioFlow Medtech Co., Ltd.
and the Executive Director & VP-Total Solutions at MicroPort CardioFlow Medtech Corp.
Prior to his current roles, he obtained his undergraduate degree from Nanjing University in 2002.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-07-2023 | 288 332 ( 0.01% ) | 41 629 $ | 31-03-2024 |
Actieve functies van Liang Zhao
| Bedrijven | Functie | Begin |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Director/Board Member | 26-05-2022 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Director/Board Member | 26-05-2022 |
Opleiding van Liang Zhao
| Nanjing University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
